Back

Prevalence of transthyretin and immunoglobulin light chain cardiac amyloidosis in patients undergoing transcatheter aortic valve replacement

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Transcatheter valve intervention in the real world Aortic Valve Intervention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Christian Nitsche

Medical University of Vienna, Vienna (Austria)

9 More presentations in this session

Presentation thumbnail
Impact of left ventricular outflow tract sphericity on transcatheter heart valve hemodynamics and outcome after transcatheter aortic valve implantation
Doctor E. Holy (Zurich, CH)
Abstract
Presentation thumbnail
Transcatheter aortic valve implantation in patients with uninterrupted vitamin k antagonist
Doctor P. Robert (Nimes, FR)
Abstract Slides
Presentation thumbnail
Blood erythropoietin independently predicts mid-term survival after post-procedural recovery from transcatheter aortic valve replacement in aortic stenosis: a prospective study
Doctor S. Mas-Peiro (Frankfurt, DE)
Abstract
Presentation thumbnail
11 years of transcatheter aortic valve implantation in a single centre and outcomes for all 1004 patient cases completed.
Doctor P. Brennan (Belfast, GB)
Abstract Slides
Presentation thumbnail
Comparing outcomes and complications between transfemoral TAVI performed with or without echoguided puncture.
Mr J. Bouteau (Tours, FR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Transcatheter valve intervention in the real world

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources